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Background: Abrupt and life-threatening presentations in connective tissue diseases (CTD) are rarely reported.
Their early recognition and specific management could change course disease. SLE is a multisystem inflammatory
disease that is often difficult to diagnose in the emergency department (ED).
Case presentation: A 26-year-old woman presented to the ED with a 48 hour history of progressive dispnea,
generalized edema and left lower chest pain with non-productive cough. On examination, patient was feeling very
ill, afebrile, tachycardic, tachypneic and a peripheral oxygen saturation of 94% on 40% supplemented oxygen with
raised jugular venous pressure was noted. Intermittently, she presented an obtunded state of consciousness. A
large pericardial, pleural and abdominal effusion was confirmed and a broad differential diagnosis was made. The
patient had a 6 months history of inflammatory polyarthralgias involving initially interphalangeal joints, evolving,
sometime later, the knees and elbows bilaterally and she was started glucocorticoids. 12 days before admission, she
had had symptoms of a urethritis episode. In the context of an immunosupressed patient, with initial focal urologic
complains, evidence of multiorgan dysfunction and a picture resembling a distributive shock, dictated a low
threshold for sepsis.
Conclusions: Separating an acute episode of SLE from sepsis, on emergency grounds, can even be the most
challenging decision. In the ED, acute life-threatening and multisystemic conditions should arise the suspicion of
autoimmune diseases, particularly SLE.Background
Abrupt and life-threatening presentations in connective
tissue diseases (CTD) are rarely reported. Their early
recognition and specific management could change
course disease. SLE is a multisystem inflammatory dis-
ease that is often difficult to diagnose in the emergency
department [1]. To the emergencist, it`s important to
consider SLE as possibility, when faced with a patient
with symptoms and/or signs suggesting a multisystem
disorder. Emergent complications of SLE are managed
in the usual manner the most described being: strokes,
acute myocardial infarctions, hemoptysis, respiratory
distress and pulmonary emboli [2-4]. Other complica-
tions, such as pericardial tamponade [1], pulmonary* Correspondence: carloscapela@ecsaude.uminho.pt
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distribution, and reproduction in any mediumhemorrhage, renal failure, or cerebritis should be man-
aged with appropriate subspecialist consultation.Case presentation
A 26-year-old Portuguese woman presented to the emer-
gence department with a 48 hour history of progressive
dispnea, generalized edema and left lower chest pain
with non-productive cough. The patient had a 6 months
history of inflammatory polyarthralgias involving initially
interphalangeal joints, evolving, at some time later, the
knees and elbows bilaterally. After ongoing rheumatolo-
gist evaluation, she started prednisolone 10 mg qd and
hydroxychloroquine 400 mg qd, while waiting laboratory
results. 12 days before admission, she had had symptoms
of a urethritis episode, associated with unexplained an-
orexia and asthenia, which led her to suspend the thera-
peutic, even against medical advice. On examination,
patient was feeling very ill, afebrile, with tachycardia
(144 bpm), tachypnea (34/min), blood pressure 143/
82 mmHg, peripheral oxygen saturation of 94% on 40%tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 2 CT scan showing pleura-pericardial effusion.
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tently she presented an obtunded state of consciousness.
Aside a diffuse moderate edema and a livedoid skin dis-
coloration, an erythematous rash over the cheeks and
nasal bridge was noted. On auscultation heart sounds
were found to be diminished and diffuse coarse crackles
were noted on both lungs, with depressed vocal trans-
mission in right basal thorax. Abdominal examination
revealed moderate hepatomegaly and ascites. The elec-
trocardiogram showed atrial fibrillation and low voltage
QRS complexes. On chest roentgenogram (Figure 1)
cardiomegaly and right pleural effusion were evident.
Initial arterial blood gas showed metabolic acidosis
(pH-7.134, PCO2-18 mm Hg, PO2-85 mm Hg, and
HCO3-6 mEq/L). Intravenous fluid replacement was
started, blood and urine were sent for culture and treat-
ment was started with empiric antibiotics (ceftriaxone
2 g iv id plus ciprofloxacin 400 mg iv bid) and methyl-
prednisolone 1 g iv bolus for 3 days. Patient was
admitted to a high-dependency unit (HDU) for further
evaluation, monitoring and support. An ultrasound of
the heart showed a large circumferential pericardial effu-
sion without signs of tamponade, which to the consulted
assistant cardiologist merit only monitoring. Comple-
mentary CT scan (Figures 2 and 3) excluded pulmonary
embolism or other thrombotic events, revealed an
enlarged and homogeneous liver and confirmed
pleuropericardial effusion and ascites. The laboratory sur-
vey revealed a white blood cell count (WBC) of 5.300
cells/mm3, with 70% polymorphonucleated cells (PMNs),
a platelet count of 417.000 per mm3 and hemoglobin
7,8 g/dL. Her INR was 2.4. An extended metabolic and
liver panel demonstrated: sodium 131 mmol/L, BUN
38.4 mg/dL, creatinine 1.4 mg/dL, total bilirubin 0.62 mg/
dL, AST 401 U/L, ALT 85 U/L, and alkaline phosphatase
128 U/L. Ammonia was 38 μmol/L. C reactive protein
160 mg/l and ESR 87 mm/h. Urine evaluationFigure 1 Chest roentgenogram showing cardiomegaly and
right pleural effusion.demonstrates > 50 leucocytes and erythrocytes per high-
power field, associated with proteinuria > 75 mg/dL Mean-
while, an immunologic panel, done 1 month earlier, was
sent to us, showing: polyclonal hypergammaglobulinemia;
positive ANA (1:160), anti-dsDNA antibodies (75 UI/mL)
with positivity to anti SSA, SSB and Histone. Pleural fluid
analysis showed an exsudate with no bacteria on a Gram
stain. By the 2nd HDU day patient was feeling much bet-
ter with remarkable edema regression. Blood gas normal-
ized. The microbiologic results of the blood, pleural fluid
and urine cultures became negative and antibiotherapy
was suspended. Immunological panel revealed frank
hypocomplementemia (C3 <1 UI; C4 – 9 UI; CH50 <10
UI); ANA (1:320), anti-dsDNA antibodies (175 UI/mL)
with persisting positivity to anti SSA, SSB and Histone, as
well as hypergammaglobulinemia and a direct positive
Coombs test. A 24 hour urine collection demonstratesFigure 3 An enlarged liver and ascites. CT scan showing an
enlarged and homogeneous liver (A) and ascites (B).
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pital day, on a therapeutic regimen of 60 mg/day of pred-
nisolone plus hydroxychloroquine 400 mg/day, after an
arrangement with the nephrologic clinic to eventually
proceed to a renal biopsy.
Conclusions
In this patient, SLE diagnostic criteria were accomplished
when malar rash, polyserositis and positive immunology
were summed to the previous described anamnestic fea-
tures. All clinical and laboratory parameters pointed to a
very active clinical process. As so, a true flare or a first full
presentation of SLE were both tentative hypothesis, consid-
ering the short duration of the disease since she first call for
medical attention and voluntary suspension of therapy. Such
an explosive clinical presentation, in the context of an
immunosupressed patient, with initial focal urologic com-
plains, evidence of multiorgan dysfunction and a picture re-
sembling a distributive shock, dictated a low threshold for
sepsis and the decision to treat with antimicrobials until in-
fection was surely excluded. This option was supported by
generalized knowledge that, in sepsis, the prognosis varies
with the elapsed time and the precocity and aggressivity of
the initial measures. Separating an acute episode of SLE
from sepsis, on emergency grounds, can even be the most
challenging decision. We have also seen such a dramatic
clinical picture in young people, particularly women, with
catastrophic antiphospholypid syndrome, which led us
to consider it in this patient. In retrospect, the full
immunossupression with glucocorticoids aborted the poten-
tial negative consequences of the active SLE, and allowed a
conservative approach to a potential lifethreatning conse-
quence of a large pericardial effusion [5,6]. It remain un-
answered if it was a real flare or the full expression of a
progressing lupus, and perhaps it would turn an academic
question in face of pressing clinical situations like this one,
where treating with a structured reasoning, considering
acute presentations of connective tissue disease and its com-
plications will be more important and rewarding.
In the emergency department, acute life-threatening
and multisystemic conditions should arise the suspicion
of autoimmune diseases, particularly SLE. Circulating
immune complexes and autoantibodies with multiples
specificities, diffusely deposit and attack a multitude of
organic targets, activating complement and mounting a
full inflammatory response, provide a substract for the
proteiform clinical e laboratorial expression of this dis-
ease. Usually, albeit impressive and frightening, the dif-
ferent manifestations can be successfully managed by
adequate, early and full immunossupression [7].
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